Nicopure Labs Challenges the FDA’s Deeming Rule
jclark2016-05-10T19:15:32+00:00
May 10, 2016 — TAMPA, FL — Nicopure Labs, LLC, the leading manufacturer of American made e-liquids was the first to file suit in the U.S. District Court for the District of Columbia, challenging the FDA’s deeming rule that would subject electronic cigarettes and other vaping products to more onerous restrictions than combustible cigarettes under the Tobacco Control Act.
In its court filing Nicopure Labs, who is not affiliated with any tobacco company, contends the FDA’s rulemaking process violated the Administrative Procedure Act, and that the deeming rule violates the First Amendment to the United States Constitution.
